Library

feed icon rss

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    Electronic Resource
    Electronic Resource
    Oxford, UK : Blackwell Publishing Ltd
    Scandinavian journal of immunology 21 (1985), S. 0 
    ISSN: 1365-3083
    Source: Blackwell Publishing Journal Backfiles 1879-2005
    Topics: Medicine
    Notes: Cord blood lymphocytes (CBL) have been shown to be functionally immature compared with normal circulating adult lymphocytes (NAL). Differentiation of T cells is associated with changes in surface antigenic markers and in the pattern of purine degradative enzymes. Previous studies have demonstrated that thymosin fraction 5 (TMS-F5) and thymosin alphal (TMS-α1 can induce in vitro differentiation of murine T-cell precursors and human thymocytes. We have investigated the effects of TMS-F5 and TMS-a, on the pattern of the purine degradative enzymes adenosine deaminase, purine nucleoside phosphorylase, and ecto-5′-nucleotidase (5′NT) of CBL and on the phenotypic markers from the OKT series 3,4,8 and 11. Other than a significantly reduced level of 5′NT activity (P〈0.001) and an elevated percentage of OKT4+cells (P〈0.01), CBL demonstrated the same immunological and biochemical patterns as NAL. Incubation of CBL with TMS-F5 (150 jug/ml) and TMS-α1 (1 μ/ml) for 40 h caused a significant rise in 5′NT level and decrease of cells positive for OKT4, resulting in a pattern characteristic of NAL. Thus TMS-F5 might induce the terminal differentiation of CBL, and TMS-α1 seemed to be the active component.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 2
    ISSN: 1432-1440
    Keywords: Muskeldystrophie vom Duchenne-Typ ; Membrandefekt ; Capping ; Konduktorinnen ; Duchenne muscular dystrophy ; Membrane defect ; Capping ; Carrier detection
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Description / Table of Contents: Summary Recent results showed that Duchenne muscular dystrophy is probably associated with a generalized membrane defect. The capping phenomenon in lymphocytes indicates normal intramembrane protein mobility and disturbances of this phenomenon are is believed to reflect membrane alterations. We have investigated capping in lymphocytes from 19 patients with Duchenne muscular dystrophy, 13 carriers, 8 patients' sisters, 14 patients' aunts and 52 normal controls. All 19 patients showed a reduction in capping both with fluorescein conjugated polyvalent goat antiserum (mean±SD=18.5±5.2%) and with fluorescein labeled Concanavalin A (mean±SD=10.8±3.2%) as compared to controls. Normal persons (n=52) have a mean of 50.2±9.9% (SD) capping with polyvalent anti-immunoglobulin (range: 32–72.5%) and 25.6±3.6% with F-Con A (range: 18.5–31.5%). 12 of the 13 mothers, as well as 5 of the 8 patients' sisters, also exhibited decreased lymphocyte capping to the same extent as the patients. Creatine kinase activity (CK) was elevated only in 4 mothers and 2 of the sisters. Our results indicate that this method might be of value in detecting carriers and can yield less false negative results as the CK-activity test.
    Notes: Zusammenfassung Es liegen Hinweise dafür vor, daß der progressiven Muskeldystrophie vom Duchenne-Typ (DMD) ein generalisierter Membrandefekt zugrunde liegt. Eine Möglichkeit zum Nachweis einer gestörten Membranfunktion stellt die Untersuchung des Capping-Phänomens von Lymphozyten dar. Es handelt sich dabei um eine fluoreszenzmikroskopisch erfaßbare Umverteilung der Oberflächen-Rezeptoren nach Antigenkontakt. Wir haben das Capping-Phänomen bei 19 Patienten und Angehörigen von 13 Familien mit DMD untersucht und dabei folgende Ergebnisse gewonnen: Lymphozyten von Kontrollpersonen zeigten mit Fluorescein markiertem Antiserum gegen Immunglobuline mit 50,2±9,9% (Mittelwert±SD) ein positives Capping-Phänomen und mit Fluorescein markiertem Concanavalin A (F-Con A) 25,6±3,6% (Mittelwert±SD). Demgegenüber war bei Patienten mit DMD, bei denen stark erhöhte Kreatin-Phosphokinase Werte (CK) gefunden wurden, das Capping-Phänomen mit Antiserum auf durchschnittlich 18,5±5,2% (Mittelwert±SD) vermindert und mit F-Con A auf 10,8±3,2% (Mittelwert±SD). Bei 12 der 13 Mütter, sowie bei 5 der 8 Schwestern der Patienten wurde ein vermindertes Capping in demselben Ausmaß wie bei den Patienten nachgewiesen. CK-Aktivität war jedoch nur bei 4 Mütter und 2 Schwestern pathologisch erhöht. Unser Ergebnis unterstützt die Hypothese, daß die Muskeldystrophie vom Duchenne-Typ mit einem generalisierten Membrandefekt einhergeht. Dieser Defekt läßt sich mittels Capping außerdem auch bei sonst “stummen” Konduktorinnen nachweisen. Diese Methode könnte sich bei der genetischen Beratung als wertvoll erweisen, da sie nach den bisherigen Ergebnissen weniger falsch negative Resultate liefert, als die alleinige Bestimmung der CK-Aktivität im Serum.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 3
    ISSN: 1432-1440
    Keywords: Deoxycoformycin ; Hairy cell leukemia ; Refractory treatment
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Summary Three patients with advanced hairy cell leukemia received low-dose deoxycoformycin treatment after failure to respond to therapy with interferon alpha. Patients 1 and 2 had progressive disease after splenectomy and subsequent treatment with recombinant interferon alpha (for 7 and 3 months, respectively). DCF was administered at 4 mg/m2 weekly for 3 weeks, and then once every week for 6 weeks. Patient 1 was in complete remission after 9 weeks of treatment and patient 2 in partial remission with normalization of peripheral blood counts. The third patient, also splenectomized, developed hepatotoxicity after therapy trial with interferon for 24 days and no objective improvement was observed at this stage. She subsequently responded to DCF treatment with improvements in blood counts and bone marrow. This report demonstrates that DCF is highly effective in hairy cell leukemia and non-cross-resistant with interferon alpha.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 4
    Electronic Resource
    Electronic Resource
    Springer
    Journal of molecular medicine 65 (1987), S. 247-252 
    ISSN: 1432-1440
    Keywords: Glucocorticoid receptors ; Glucocorticoid resistance ; Lymphocytolysis ; Lymphoid neoplasia
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Summary A generalized view on the mechanism of steroid hormone action is presented with special emphasis on glucocorticoids and their lymphocytolytic effects. The present knowledge on the structure and function of glucocorticoid receptors is reviewed. Following hormone binding, the receptor complex is activated to a form which is able to interact with chromatin or DNA. Several types of receptor mutants have been obtained in an animal cell culture system which allows selection of cell variants. The biochemical analysis of these mutants helped to establish a domain model of receptor structure. The quantitative effect of receptor numbers and hormone activity on lymphocytolysis is described in a cell culture model system and the results are discussed in view of the rational treatment of lymphoid neoplasia with glucocorticoids. The clinical experience with glucocorticoids alone and in combination therapy with cytostatic drugs is summarized. Our special emphasis is on acute lymphoblastic leukemia and malignant lymphoma as patients with these diseases can now be treated with remarkable success rates.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 5
    Electronic Resource
    Electronic Resource
    Springer
    Journal of molecular medicine 58 (1980), S. 43-45 
    ISSN: 1432-1440
    Keywords: Glucocorticoid-Rezeptoren ; Leukämien ; Sensitivität ; Glucocorticoid receptors ; Leukemias ; Sensitivity
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Description / Table of Contents: Summary Determination of steroid receptors has been used to predict steroid sensitivity in various neoplasias. In an attempt to investigate its applicability in human leukemias we have studied glucocorticoid receptors in the leukemic cells from 23 patients with various hematologic neoplasias and in the lymphocytes from 18 normal donors. Specific glucocorticoid binding in intact cells was determined by a whole cell competitive binding assay. Normal lymphocytes have about 4,611 specific binding sites per cell. The blasts from 9 patients with acute myelogenous leukemias (AML) have strongly varying high levels of specific binding sites, ranging from 4,817 to 15,416 per cell. Of the 13 patients with chronic lymphocytic leukemia (CLL), 5 have received glucocorticoid treatment for years and were clinically resistant to glucocorticoid. Their lymphocytes have lower specific binding sites (range: 2,047 to 3,999) than the other CLL cases which were newly diagnosed (range: 3,734 to 11,020). Our results suggest that determination of glucocorticoid receptors might be of value in predicting clinical responsiveness in leukemias.
    Notes: Zusammenfassung Bei einigen steroid-sensitiven Neoplasien ist die Bestimmung von Steroid-Rezeptoren für die Voraussage einer Ansprechbarkeit auf die Hormontherapie von Bedeutung. Um die Anwendung dieser Methode auch bei Leukämien nachzuprüfen, haben wir die Glucocorticoid-Rezeptoren in Leukämiezellen von 23 Patienten und in Lymphozyten von 18 Kontrollpersonen untersucht. Die Bestimmung erfolgte nach einer Methode nach Baxter und Tomkins. Normallymphozyten haben circa 4611 spezifische Bindungsstellen pro Zelle. Der Anzahl der Steroid-Rezeptoren in den Blasten von 9 Patienten mit AML schwankten stark (Bereich: 4817–15416 Stellen/Zelle). Fünf von 13 Patienten mit CLL wurden seit Jahren mit Glucocorticoid behandelt und sprachen zur Zeit der Rezeptoren-Bestimmung auf die Therapie nicht mehr an. Die Anzahl der Bindungsstellen der Lymphozyten dieser Patienten war im Mittel niedriger (Bereich: 2047–3999), als bei den Patienten, die neu diagnostiziert worden waren (Bereich: 3734–11020). Unsere Ergebnisse weisen darauf hin, daß die Bestimmung von Steroid-Rezeptoren für die Planung einer Therapie mit Glucocorticoiden von Bedeutung sein könnte.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 6
    ISSN: 1432-1076
    Keywords: Duchenne muscular dystrophy ; Membrane defect ; Capping ; Carrier detection
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Abstract There has been considerable interest in capping of lymphocytes in patients with Duchenne muscular dystrophy (DMD). However, the results from different authors are controversial. We have investigated cap formation in thirteen families with DMD, using a method standardized in our laboratory, and could establish diminished capping in all 12 patients and in 12 of the 13 mothers. By examining cap formation simultaneously with whole polyvalent antiserum, with F(ab)2 fragment of polyvalent antiserum, and with monospecific antisera we could also confirm this observation of defective capping in 7 patients and 4 carriers, as compared to 9 control subjects likewise examined. We have indications that treatment of the lymphocytes under unfavourable conditions e.g. preincubation in buffer solution might accentuate the decrease of lymphocyte capping in patients and carriers.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 7
    Electronic Resource
    Electronic Resource
    Springer
    Annals of hematology 42 (1981), S. 183-190 
    ISSN: 1432-0584
    Keywords: Glucocorticoid-Rezeptoren ; Sensitivität ; Leukämie ; Glucocorticoid receptors ; Sensitivity ; Leukemias
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Description / Table of Contents: Summary In an attempt to investigate the utility of glucocorticoid receptor determination to predict clinical responsiveness in human leukemias we have studied glucocorticoid receptors in the leukemic cells from 46 patients and in the lymphocytes from 18 normal donors. In the normal lymphocytes there were 3,875 (Median) specific binding sites per cell. The blasts from 17 patients with ANLL had on average higher levels of binding sites per cell (Median = 7,250, range: 0 to 15,295) than the other leukemias. Of the 15 patients with CLL, six had received glucocorticoid treatment for 3 to 5 years. Their lymphocytes had lower number of receptors (Median = 2,000) than the other cases which were newly diagnosed (Median = 4,500). Four patients had ALL/AUL, three patients had blast crisis as terminal phase of CML, and seven had leukemic Non-Hodgkin lymphomas (Median = 3,500 sites/cell). In 24 patients we have also studied the in vitro sensitivity of the leukemic cells to dexamethasone. There was no marked correlation between glucocorticoid receptor levels and in vitro sensitivity. An attempt to correlate receptor levels with clinical responsiveness demonstrated that glucocorticoid receptor determination might be of value in patients with lymphoid malignancies but probably not in patients with other leukemias.
    Notes: Zusammenfassung Zur Prüfung der Frage, ob eine positive Korrelation zwischen dem Steroid-Rezeptorgehalt von Leukämiezellen und dem Erfolg einer Steroid-Therapie besteht, haben wir Glucocorticoid-Rezeptoren bei Leukämien und Lymphomen untersucht. Die Bestimmung erfolgte nach Baxter und Tomkins. Untersucht wurden 46 Patienten mit Leukämien und 18 Kontrollpersonen. Normale Lymphozyten haben durchschnittlich 3875 spezifische Bindungsstellen pro Zelle. Die Anzahl der Glucocorticoid-Rezeptoren in den Blasten von 17 Patienten mit akuter myeloischer Leukämie zeigten starke Schwankungen (Bereich 0 bis 15295 Rezeptoren pro Zelle). Sechs von 15 Patienten mit chronischer lymphatischer Leukämie wurden seit Jahren mit Glucocorticoiden behandelt und sprachen zur Zeit der Steroid-Rezeptor-Bestimmung auf diese Therapie nicht mehr an. Die Anzahl der Steroid-Bindungsstellen der Lymphozyten dieser Patienten erwies sich im Mittel als niedriger (2000 je Zelle) als bei den unbehandelten Patienten (4500 je Zelle). Bei 24 Patienten haben wir auch die In-Vitro-Sensitivität der Leukämiezellen gegenüber Dexamethason untersucht. Es konnte keine eindeutige Korrelation zwischen Rezeptorengehalt und In-Vitro-Sensitivität festgestellt werden. Weitere Analysen mit klinischen Daten weisen darauf hin, da\ die Bestimmung von Glucocorticoid-Rezeptoren für die Planung und Durchführung einer Therapie bei den lymphatischen Leukämien Bedeutung erlangen kann, jedoch wahrscheinlich nicht bei den myeloischen Leukämien.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 8
    ISSN: 1432-0584
    Keywords: Key words Autologous transplantation ; Hodgkin's disease ; Mobilization ; Prognostic factors ; Peripheral blood stem cell transplantation
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Abstract  From March 1986 to March 1998, 82 patients with relapsed or refractory Hodgkin's disease underwent high-dose chemotherapy (HDCT) with peripheral blood stem cell (PBSC) transplantation in our center. This is a retrospective analysis of the long-term clinical outcome. There were 52 males and 30 females with a median age of 32 years (range 18–59 years). Prior to transplantation, 36 patients were in complete remission (CR), 34 in partial remission (PR), and 12 had refractory disease after salvage therapy. For HDCT, 78 patients were treated with CBV (cyclophosphamide, 6.0–6.8 g/m2; etoposide, 1.0–1.6 g/m2; carmustine, 0.45–0.8 g/m2), while four patients received different regimens. Probability of freedom from progression (FFP), overall survival (OS), and event-free survival (EFS) at 5 years of the entire group was 63%, 61%, and 54%, respectively. Early mortality rate (≤100 days) declined from 17% to 6% after 1992. Five patients died of late transplant-related complications (〉100 days), including secondary lymphoma and leukemia in two patients. None of the refractory patients survived beyond 3.5 years. Multivariate analyses identified extranodal sites of disease at relapse and refractory disease status prior to transplantation as significant prognostic factors for FFP, EFS, and OS. As we have shown in our study, remarkable progress was achieved in reducing early morbidity and mortality over time, but this was associated with only a slight, not significant improvement of long-term outcome (OS 66% vs 57% at 5 years for patients undergoing PBSC transplantation before and after 1992, P=0.26). Although the results as a whole are encouraging for chemosensitive patients, new therapeutic strategies are needed to reduce toxicity and improve the clinical outcome of patients, especially of those with a less favorable prognosis.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 9
    ISSN: 1432-0584
    Keywords: Autologous bone marrow transplantation ; Acute leukemia ; 4-hydroperoxycyclophosphamide
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Summary An autologous bone marrow transplantation (ABMT) was performed in a 45-year-old male patient with AML in therapy-resistant first relapse including CNS-disease. The marrow graft was harvested 18 months before, at the beginning of first remission, and was subjected to an in-vitro incubation with 4-hydroperoxycyclophosphamide (4-HC) prior to cryopreservation to eliminate residual clonogenic tumor cells. After myeloablative therapy with high-dose Cyclophosphamide (CY), total body irradiation (TBI) and intrathecal application of Methotrexate (MTX), the manipulated marrow graft was reinfused. The myelopoietic reconstitution started already 6 days after ABMT and was completed 40 days thereafter. There is evidence for a complete remission in marrow and spinal fluid observed over a period of 4 months.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 10
    Electronic Resource
    Electronic Resource
    Springer
    Annals of hematology 41 (1980), S. 451-454 
    ISSN: 1432-0584
    Keywords: Progressive multifokale Leukoenzephalopathie ; neurologische Symptome ; Morbus Hodgkin ; Progressive multifocal leukoencephalopathy ; Neurological symptoms ; Hodgkin's disease
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Description / Table of Contents: Summary This is a report on a 78-year-old patient with Hodgkin's disease of mixed cell type in stage III B, who, because of his age, underwent only mild cytostatic therapy. Two months after beginning of treatment, cerebellar neurological symptoms developed. He died of bronchopneumonia 3 months later. At autopsy progressive multifocal leukoencephalopathy with multiple demyelinated areas in the cerebellum was established. Paracristallinic structures within nuclei of glial cells resembling papovavirus formations were detected by electron microscopy.
    Notes: Zusammenfassung Bericht über einen 78jährigen Patienten mit Morbus Hodgkin vom gemischtzelligen Typ in Stadium III B, der wegen seines Alters nur eine milde zytostatische Behandlung bekommen hatte. Zwei Monate nach Einleitung der Therapie entwickelten sich cerebelläre neurologische Symptome; nach weiteren 3 Monaten verstarb der Patient an Bronchopneumonie. Bei der Obduktion wurde eine progressive multifocale Leukoenzephalopathie mit multiplen demyelinierten Bezirken im Cerebellum festgestellt. Elektronenmikroskopisch fanden sich parakristalline Strukturen innerhalb der Glia-Zellkerne, die Papovaviren ähnelten.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...